W. Hespe

566 total citations
30 papers, 438 citations indexed

About

W. Hespe is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, W. Hespe has authored 30 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in W. Hespe's work include Neuroscience and Neuropharmacology Research (8 papers), Analytical Methods in Pharmaceuticals (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). W. Hespe is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Analytical Methods in Pharmaceuticals (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). W. Hespe collaborates with scholars based in United States and Netherlands. W. Hespe's co-authors include W. Th. Nauta, Eugene Roberts, Robert C. Roozemond, F. J. Zijlstra, Dirk K. F. Meijer, Judith Haffmans, O. E. Ukponmwan, J. Vincent, M.R. Dzoljic and Mark J. Ernsting and has published in prestigious journals such as Brain Research, Journal of Chromatography A and Biochemical Pharmacology.

In The Last Decade

W. Hespe

29 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Hespe United States 10 203 158 66 55 54 30 438
D. Hellenbrecht Germany 12 95 0.5× 185 1.2× 62 0.9× 80 1.5× 25 0.5× 36 432
R Nickander United States 11 111 0.5× 140 0.9× 133 2.0× 24 0.4× 51 0.9× 18 467
Lawrence F. Sancilio United States 15 158 0.8× 230 1.5× 119 1.8× 93 1.7× 55 1.0× 39 721
Jerome R. Bagley United States 13 135 0.7× 194 1.2× 63 1.0× 83 1.5× 67 1.2× 31 613
D. Scott Wright United States 13 103 0.5× 204 1.3× 48 0.7× 44 0.8× 38 0.7× 32 520
A. F. Crowther United Kingdom 11 74 0.4× 241 1.5× 56 0.8× 58 1.1× 52 1.0× 16 784
J. Rosenthaler Japan 16 106 0.5× 198 1.3× 80 1.2× 115 2.1× 87 1.6× 32 788
Annalisa Lippi Italy 12 184 0.9× 208 1.3× 27 0.4× 28 0.5× 48 0.9× 36 575
Ronald G. Wiegand United Kingdom 13 89 0.4× 139 0.9× 67 1.0× 16 0.3× 36 0.7× 22 433
P Schiantarelli Italy 11 101 0.5× 131 0.8× 64 1.0× 57 1.0× 30 0.6× 34 381

Countries citing papers authored by W. Hespe

Since Specialization
Citations

This map shows the geographic impact of W. Hespe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Hespe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Hespe more than expected).

Fields of papers citing papers by W. Hespe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Hespe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Hespe. The network helps show where W. Hespe may publish in the future.

Co-authorship network of co-authors of W. Hespe

This figure shows the co-authorship network connecting the top 25 collaborators of W. Hespe. A scholar is included among the top collaborators of W. Hespe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Hespe. W. Hespe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hespe, W., et al.. (1987). Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration.. PubMed. 37(8). 977–9. 8 indexed citations
2.
Hespe, W., et al.. (1987). Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics.. PubMed. 37(3). 372–5. 10 indexed citations
3.
Haffmans, Judith, O. E. Ukponmwan, F. J. Zijlstra, et al.. (1983). Correlation between the distribution of 3H-labelled enkephalin in rat brain and the anatomical regions involved in enkephalin-induced seizures. Neuropharmacology. 22(8). 1021–1028. 23 indexed citations
4.
Hespe, W., et al.. (1977). Sensitive and specific gas chromatographic and extraction method for the determination of orphenadrine in human body fluids. Journal of Chromatography A. 144(2). 201–208. 10 indexed citations
5.
Hespe, W., et al.. (1976). Topical and Systemic Effects of Hydrocortisone 17-Butyrate. Dermatology. 152(Suppl. 1). 181–195. 6 indexed citations
6.
Hespe, W., et al.. (1975). A combined study on the distribution of oxytetracycline and polyvinylpyrrolidone in rats.. PubMed. 25(10). 1561–7. 3 indexed citations
7.
8.
Hespe, W., et al.. (1972). Uptake and excretion of the quaternary ammonium compound deptropine methiodide in the isolated perfused rat liver. Naunyn-Schmiedeberg s Archives of Pharmacology. 275(2). 183–192. 8 indexed citations
9.
10.
Hespe, W., Mark J. Ernsting, & W. Th. Nauta. (1969). The effect of orphenadrine hydrochloride on the acetylcholine concentration in rat brain. International Journal of Neuropharmacology. 8(5). 471–474. 2 indexed citations
11.
Hespe, W., et al.. (1969). A comparative autoradiographic study on the distribution of deptropine citrate and deptropine methiodide in mice. Biochemical Pharmacology. 18(1). 53–57. 6 indexed citations
12.
Hespe, W., et al.. (1969). Distribution of tritium-labelled tofenacine hydrochloride in the pregnant mouse. European Journal of Pharmacology. 8(1). 119–126. 2 indexed citations
13.
Hespe, W., et al.. (1968). Autoradiographic study of the distribution of radioactivity in mice after oral administration of tritium-labelled orphenadrine hydrochloride.. PubMed. 171(1). 47–57. 3 indexed citations
14.
Roozemond, Robert C., W. Hespe, & W. Th. Nauta. (1968). The concentrations of orphenadrine and its N-demethylated derivatives in rat brain, after intraperitoneal administration of orphenadrine and tofenacine. International Journal of Neuropharmacology. 7(3). 293–300. 8 indexed citations
15.
Hespe, W., et al.. (1968). Investigations into the metabolic fate and distribution of hepzidine maleate in the rat and the mouse. Biochemical Pharmacology. 17(5). 655–666. 7 indexed citations
16.
Hespe, W., et al.. (1967). The distribution and metabolic fate of xyloxemine hydrochloride in mice and rats.. PubMed. 170(2). 397–408. 2 indexed citations
17.
Hespe, W., et al.. (1967). Evidence for side-chain degradation of orphenadrine HCl in the rat. Biochemical Pharmacology. 16(9). 1847–1848. 2 indexed citations
18.
Hespe, W. & W. Th. Nauta. (1966). The labelling with tritium of 2‐(dimethylamino)ethanol and of some drugs containing the 2‐(dimethylamino)ethyl group as a structural part. Journal of Labelled Compounds. 2(2). 193–197. 5 indexed citations
19.
Hespe, W., et al.. (1965). Investigation into the metabolic fate of orphenadrine hydrochloride after oral administration to male rats.. PubMed. 156(1). 180–200. 11 indexed citations
20.
Hespe, W., et al.. (1965). The synthesis of [6,7‐T]‐tropine. Recueil des Travaux Chimiques des Pays-Bas. 84(4). 476–480. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Hellenbrecht Breakdown of academic impact, for papers by R Nickander Breakdown of academic impact, for papers by Lawrence F. Sancilio Breakdown of academic impact, for papers by Jerome R. Bagley Breakdown of academic impact, for papers by D. Scott Wright Breakdown of academic impact, for papers by A. F. Crowther Breakdown of academic impact, for papers by J. Rosenthaler Breakdown of academic impact, for papers by Annalisa Lippi Breakdown of academic impact, for papers by Ronald G. Wiegand Breakdown of academic impact, for papers by P Schiantarelli
Rankless by CCL
2026